Home » Tenders » Asia » Japan » A Bictegravir Sodium Emtricitabine Tenofovir Alafenamide Fumarate (30Tablets/Vial)... Tender

A Bictegravir Sodium Emtricitabine Tenofovir Alafenamide Fumarate (30Tablets/Vial)... Tender

Download Documents

NATIONAL UNIVERSITY CORPORATION has floated a tender for A Bictegravir Sodium Emtricitabine Tenofovir Alafenamide Fumarate (30Tablets/Vial) 420Vials, And 50 other Contracts. The project location is Japan and the tender is closing on 14 Mar 2024. The tender notice number is , while the TOT Ref Number is 95553851. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Japan

Summary : A Bictegravir Sodium Emtricitabine Tenofovir Alafenamide Fumarate (30Tablets/Vial) 420Vials, And 50 other Contracts

Deadline : 14 Mar 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 95553851

Document Ref. No. :

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : NATIONAL UNIVERSITY CORPORATION
Hiromasa Kawada, Procurement Section, Niigata University Medical And Dental Hospital, 754 Asahimachidori 1-Bancho Chuo-Ku Niigata-Shi 951-8520 Japan, Tel 025-227-2430
Japan

Tender Details

A Bictegravir sodium Emtricitabine Tenofovir alafenamide fumarate (30tablets/vial) 420vials, and 50 other contracts
Classification :
0004 Medical & Pharmaceutical Products
Summay of Notice :
⑴ Official in charge of disbursement of the procuring entity : Tatsuo Ushiki, President, National University Corporation Niigata University
⑵ Classification of the products to be procured : 4
⑶ Nature and quantity of the products to be purchased :
A Bictegravir sodium Emtricitabine Tenofovir alafenamide fumarate (30tablets/vial) 420vials
B Letermovir (240㎎ 14tablets/case) 300 cases
C Olaparib (100㎎ 56tablets/case) 140 cases
D Olaparib (150㎎ 56tablets/case) 420 cases
E Aflibercept (Genetical Recombination) (2㎎ 0.05mL/syringe) 480syringes
F Vutrisiran Sodium Kit (25㎎ 0.5mL/syringe) 4syringes
G Tocilizumab (Genetical Recombination) (200㎎ 10mL/vial) 1, 320vials
H Tocilizumab (Genetical Recombination) (162㎎ 0.9mL/kit) 1, 080cases
I Paclitaxel (100㎎/vial) 1, 300vials
J Cetuximab (Genetical Recombination) (100㎎ 20mL/vial) 1, 350vials
K Bevacizumab (Genetical Recombination) (100㎎ 4mL/vial) 870vials
L Bevacizumab (Genetical Recombination) (400㎎ 16mL/vial) 1, 100vials
M Durvalumab (Genetical Recombination) (120㎎ 2.4mL/vial) 460vials
N Durvalumab (Genetical Recombination) (500㎎ 10mL/vial) 450vials
O Canakinumab (Genetical Recombination) (150㎎ 1mL/vial) 30vials
P Nivolumab (Genetical Recombination) (100㎎ 10mL/vial) 210vials
Q Abatacept (Genetical Recombination) (250㎎/vial) 500vials
...